Table 1.

Relationship between parasitemia, anemia, and reticulocyte count

Response to infectionAotusno.Peak parasitemia % (day)Day of treatmentReticulocyte %*(Hematocrit %)
Day 7 (8)Day 14 (15)Day 21 (22)Day 29 (29)Day 36 (36)
Group 1: No microscopically detectable parasitemia; no anemia 5231-153  2.8  (58) 7.8  (53) 1.5  (49) 6.5  (56) 4.9  (63) 
5301-153  6.8  (64) 5.9  (60) 3.4  (64) 2.3  (66) 4.9  (68) 
5591-153,1-154  4.0  (58) 3.5  (49) 3.3  (46) 6.3  (57) 2.6  (61) 
6031-153  3.8  (44) 1.5  (43) 1.6  (44) 2.3  (41) 3.8  (40) 
7321-153  3.3  (62) 4.2  (57) 2.4  (50) 12.7  (43) 5.6  (52) 
546  5.1  (60) 2.4  (56) 5.2  (61) 1.7  (66) 2.5  (71)  
602  3.1  (65) 2.7  (60) 1.7  (54) 3.0  (62) 3.6  (68) 
680  2.4  (58) 3.3  (57) 4.8  (59) 5.7  (62) 3.0  (65)  
692  2.1  (59) 5.5  (57) 1.4  (60) 1.3  (59) 2.1  (57) 
747  2.8  (57) 3.7  (51) 3.4  (51)1-164 2.2  (50) 7.6  (40) 
749  1.9  (53)1-160 3.0  (53) 2.0  (50) 1.9  (59) 2.4  (53)  
Group 2: No microscopically detectable parasitemia; positive by PCR; severe anemia (hematocrit lower than 25%) 5671-153 22 2.9  (60) 2.4  (52) 2.1  (22)1-161 14.8  (28) 10.8  (49) 
6571-153 15 4.4  (43) 2.3  (20) 16.4  (29) 14.9  (37) 11.1  (44) 
6761-153 22 2.5  (56) 1.5  (45) 0.1  (19)1-161 20.8  (27) 7.1  (48) 
26111-153,1-159 21 9.6  (60) 4.5  (45) 0.0  (16)1-161 6.3  (43) 1.5  (53) 
557 17 3.5  (52) 1.5  (29) 17.9  (26) 8.4  (18) 4.9  (25) 
7481-154 17 3.2  (55) 2.9  (30) 6.9  (22) 7.9  (32) 6.2  (50)  
Group 3: Parasitemia level lower than 5%; moderate anemia 5131-153,1-154 3.61  (20)  5.8  (57) 2.1  (56) 4.0  (34) 11.3  (36) 4.9  (47) 
5601-153 0.41  (21)  4.8  (62) 3.5  (60) 0.4  (48) 24.5  (33) 10.8  (55) 
5771-153 0.73  (21)  5.0  (54) 5.5  (53) 1.9  (34) 9.6  (49) 3.4  (62) 
6271-153 0.14  (17)  3.4  (57) 1.4  (39) 3.7  (27)1-164 11.6  (38) 9.9  (46) 
738 0.36  (12)  4.6  (62) 3.8  (39) 8.0  (37) 3.5  (49) 3.9  (52) 
5781-153  3.7  (44) 3.8  (34) 6.5  (39) 7.8  (41) 5.9  (57) 
6311-153  2.8  (59) 4.5  (52) 6.1  (39) 6.0  (45) 5.8  (54)  
Group 4: Parasitemia level lower than 5%; severe anemia 5951-153,1-154 0.31  (18) 22 3.0  (56) 1.3  (51) 2.2  (19)1-161 6.4  (27) 6.5  (49)  
6001-153 3.10  (21) 22 4.1  (54) 3.7  (52) 3.9  (24)1-161 18.4  (34) 7.1  (50)  
6061-153 0.14  (19) 22 3.5  (60) 3.3  (49) 1.8  (20)1-161 dead dead 
26121-153,1-159 0.35  (21) 24 2.9  (52) 2.7  (45) 4.4  (29) 7.1  (29) 6.6  (41) 
5851-154 0.35  (12) 16 6.2  (57) 2.6  (30) 8.6  (20) 8.8  (36) 10.4  (46)  
604 0.20  (16) 19 3.9  (57) 2.5  (41) 9.4  (23) 7.4  (48) 4.7  (54)  
Group 5: Parasitemia level equal to or greater than 5%; severe anemia 6781-154 9.70  (14) 14 5.3  (58) 7.1  (22)1-161 11.2  (40) 10.1  (59) 5.6  (63) 
Response to infectionAotusno.Peak parasitemia % (day)Day of treatmentReticulocyte %*(Hematocrit %)
Day 7 (8)Day 14 (15)Day 21 (22)Day 29 (29)Day 36 (36)
Group 1: No microscopically detectable parasitemia; no anemia 5231-153  2.8  (58) 7.8  (53) 1.5  (49) 6.5  (56) 4.9  (63) 
5301-153  6.8  (64) 5.9  (60) 3.4  (64) 2.3  (66) 4.9  (68) 
5591-153,1-154  4.0  (58) 3.5  (49) 3.3  (46) 6.3  (57) 2.6  (61) 
6031-153  3.8  (44) 1.5  (43) 1.6  (44) 2.3  (41) 3.8  (40) 
7321-153  3.3  (62) 4.2  (57) 2.4  (50) 12.7  (43) 5.6  (52) 
546  5.1  (60) 2.4  (56) 5.2  (61) 1.7  (66) 2.5  (71)  
602  3.1  (65) 2.7  (60) 1.7  (54) 3.0  (62) 3.6  (68) 
680  2.4  (58) 3.3  (57) 4.8  (59) 5.7  (62) 3.0  (65)  
692  2.1  (59) 5.5  (57) 1.4  (60) 1.3  (59) 2.1  (57) 
747  2.8  (57) 3.7  (51) 3.4  (51)1-164 2.2  (50) 7.6  (40) 
749  1.9  (53)1-160 3.0  (53) 2.0  (50) 1.9  (59) 2.4  (53)  
Group 2: No microscopically detectable parasitemia; positive by PCR; severe anemia (hematocrit lower than 25%) 5671-153 22 2.9  (60) 2.4  (52) 2.1  (22)1-161 14.8  (28) 10.8  (49) 
6571-153 15 4.4  (43) 2.3  (20) 16.4  (29) 14.9  (37) 11.1  (44) 
6761-153 22 2.5  (56) 1.5  (45) 0.1  (19)1-161 20.8  (27) 7.1  (48) 
26111-153,1-159 21 9.6  (60) 4.5  (45) 0.0  (16)1-161 6.3  (43) 1.5  (53) 
557 17 3.5  (52) 1.5  (29) 17.9  (26) 8.4  (18) 4.9  (25) 
7481-154 17 3.2  (55) 2.9  (30) 6.9  (22) 7.9  (32) 6.2  (50)  
Group 3: Parasitemia level lower than 5%; moderate anemia 5131-153,1-154 3.61  (20)  5.8  (57) 2.1  (56) 4.0  (34) 11.3  (36) 4.9  (47) 
5601-153 0.41  (21)  4.8  (62) 3.5  (60) 0.4  (48) 24.5  (33) 10.8  (55) 
5771-153 0.73  (21)  5.0  (54) 5.5  (53) 1.9  (34) 9.6  (49) 3.4  (62) 
6271-153 0.14  (17)  3.4  (57) 1.4  (39) 3.7  (27)1-164 11.6  (38) 9.9  (46) 
738 0.36  (12)  4.6  (62) 3.8  (39) 8.0  (37) 3.5  (49) 3.9  (52) 
5781-153  3.7  (44) 3.8  (34) 6.5  (39) 7.8  (41) 5.9  (57) 
6311-153  2.8  (59) 4.5  (52) 6.1  (39) 6.0  (45) 5.8  (54)  
Group 4: Parasitemia level lower than 5%; severe anemia 5951-153,1-154 0.31  (18) 22 3.0  (56) 1.3  (51) 2.2  (19)1-161 6.4  (27) 6.5  (49)  
6001-153 3.10  (21) 22 4.1  (54) 3.7  (52) 3.9  (24)1-161 18.4  (34) 7.1  (50)  
6061-153 0.14  (19) 22 3.5  (60) 3.3  (49) 1.8  (20)1-161 dead dead 
26121-153,1-159 0.35  (21) 24 2.9  (52) 2.7  (45) 4.4  (29) 7.1  (29) 6.6  (41) 
5851-154 0.35  (12) 16 6.2  (57) 2.6  (30) 8.6  (20) 8.8  (36) 10.4  (46)  
604 0.20  (16) 19 3.9  (57) 2.5  (41) 9.4  (23) 7.4  (48) 4.7  (54)  
Group 5: Parasitemia level equal to or greater than 5%; severe anemia 6781-154 9.70  (14) 14 5.3  (58) 7.1  (22)1-161 11.2  (40) 10.1  (59) 5.6  (63) 

Treatment was given for hematocrit lower than 25% or parasitemia equal to or greater than 5%.

*

Normal reticulocyte count for Aotus monkeys: 2.9% ± 2.2% (arithmetic mean ± 2 SD deduced from 34 monkeys never exposed to malaria or vaccination).

0 = not microscopically detectable or only 1 or 2 parasites seen in 29 days.

All animals not previously treated were treated on day 29.

F1-153

Immunized before first infection; all others immunized between first and second infections.

F1-154

Vaccinated with control antigen GST; all others vaccinated with MSP-119.

F1-159

A vociferans monkeys; all others were A nancymai.

F1-160

Hematocrit % on day 5.

F1-164

Hematocrit % on day 23.

F1-161

Reticulocyte % determined on day of treatment.

Close Modal

or Create an Account

Close Modal
Close Modal